Core Insights - The QDII fund market has seen significant growth, with a total scale of 582.37 billion and 312 products as of June 30, 2025, driven by domestic investors' increasing demand for overseas asset allocation [1] - There is a notable performance divergence among QDII funds in the first half of 2025, with Hong Kong and global pharmaceutical theme funds leading the performance rankings, while Southeast Asian technology, oil, and related regional theme products faced adjustment pressures [1][5] Performance Summary Top Performing QDII Funds - The top ten QDII funds in terms of returns are all focused on the pharmaceutical and biotechnology sectors, with the leading fund, 汇资高香港优势精选A, achieving a return of 86.48% [2][3] - Other notable performers include 广发中证香港创新药ETF with a 57.12% return and 华泰柏瑞恒生创新药ETF with a 56.94% return [2][3] - Smaller funds also showed strong performance, such as 工银新经济人民币 with a return of 52.92% despite a small scale of 0.45 billion [3] Underperforming QDII Funds - The bottom ten QDII funds primarily consist of Southeast Asian technology ETFs, with 华泰相瑞商力乐央新交所之东南亚科技ETF experiencing a decline of 11.66% [4][5] - Oil-themed funds also faced pressure, with 易方达原油A人民币 and 南方原油A both showing declines exceeding 5% [5] - Regional theme funds showed significant divergence, with two Saudi Arabian ETFs declining over 7%, indicating pressure from sovereign fund reductions [6] Market Outlook - Analysts believe that the Hong Kong market still offers investment value, with a focus on high-quality companies that can withstand economic cycles and dividend assets in a low-interest-rate environment [6] - There is an expectation of continued foreign capital inflow into Chinese assets as corporate earnings recover, supported by improved fundamentals and market share gains [6]
QDII基金上半年首尾差98%!汇添富香港优势精选涨86%夺冠,华泰柏瑞东南亚科技ETF跌11%垫底
Xin Lang Ji Jin·2025-07-02 09:38